I agree that this site is using cookies. You can find further informations here.
X
Girmenia C
38  results:
OpenAccess-fulltext X
Search for persons X
?
1

Myeloablative conditioning with thiotepa-busulfan-fludarabi..:

Bonifazi F ; Pavoni C ; Peccatori J...
info:eu-repo/semantics/altIdentifier/pmid/35413985.  , 2022
Link: http://hdl.handle.net/11..
 
?
2

Prognostic impact and risk factors of infections in patient..:

Mauro F. R ; Giannarelli D ; Visentin A...
info:eu-repo/semantics/altIdentifier/pmid/34209515.  , 2021
Link: http://hdl.handle.net/23..
 
?
3

Positive HCMV DNAemia in stem cell recipients undergoing le..:

Cassaniti I ; Colombo AA ; Bernasconi P...
info:eu-repo/semantics/altIdentifier/pmid/33320429.  , 2021
Link: https://hdl.handle.net/1..
 
?
4

Prognostic impact and risk factors of infections in patient..:

Mauro F. R ; Giannarelli D ; Visentin A...
info:eu-repo/semantics/altIdentifier/pmid/34209515.  , 2021
Link: https://hdl.handle.net/1..
 
?
5

COVID-19 in patients with hematologic disorders undergoing ..:

Girmenia C ; Gentile G ; Micozzi A...
info:eu-repo/semantics/altIdentifier/pmid/32932252.  , 2020
Link: http://hdl.handle.net/11..
 
?
6

Evaluating Cefiderocol in the Treatment of Multidrug-Resist..:

Giacobbe DR ; Ciacco E ; Girmenia C...
https://www.dovepress.com/evaluating-cefiderocol-in-the-treatment-of-multidrug-resistant-gram-ne-peer-reviewed-article-IDR.  , 2020
Link: https://doaj.org/article..
 
?
7

Evaluating cefiderocol in the treatment of multidrug-resist..:

Giacobbe D. R ; Ciacco E ; Girmenia C...
info:eu-repo/semantics/altIdentifier/wos/WOS:000602986200003.  , 2020
Link: http://hdl.handle.net/11..
 
?
8

Cost-effectiveness analysis of the use of letermovir for th..:

Restelli U ; Croce D ; Pacelli V..
https://www.dovepress.com/cost-effectiveness-analysis-of-the-use-of-letermovir-for-the-prophylax-peer-reviewed-article-IDR.  , 2019
Link: https://doaj.org/article..
 
?
9

Management of toxicities associated with targeted therapies..:

Cazzaniga M. E ; Danesi R ; Girmenia C...
info:eu-repo/semantics/altIdentifier/pmid/31065872.  , 2019
Link: http://hdl.handle.net/10..
 
?
10

Incidence, Risk Factors and Outcome of Pre-engraftment Gram..:

Girmenia C ; Bertaina A ; Piciocchi A...
info:eu-repo/semantics/altIdentifier/pmid/29020286.  , 2017
Link: http://hdl.handle.net/11..
 
?
11

Italian consensus conference for the outpatient autologous ..:

Martino, M ; Lemoli, R. M ; Girmenia, C...
info:eu-repo/semantics/altIdentifier/pmid/27042841.  , 2016
Link: http://hdl.handle.net/23..
 
?
12

Infections by carbapenem-resistant Klebsiella pneumoniae in..:

Girmenia C ; Rossolini GM ; Piciocchi A...
info:eu-repo/semantics/altIdentifier/pmid/25310302.  , 2015
Link: http://hdl.handle.net/23..
 
?
13

Incidence and Outcome of Invasive Fungal Diseases after All..:

Girmenia C ; Raiola AM ; Piciocchi A...
info:eu-repo/semantics/altIdentifier/pmid/24631738.  , 2014
Link: http://hdl.handle.net/23..
 
?
14

Primary Prophylaxis of Invasive Fungal Diseases in Allogene..:

Girmenia C ; Barosi G ; Piciocchi A...
info:eu-repo/semantics/altIdentifier/wos/WOS:000339464100003.  , 2014
Link: https://hdl.handle.net/2..
 
?
15

Combined antifungal approach for the treatment of invasive ..:

Pagano L ; Cornely OA ; Busca A...
info:eu-repo/semantics/altIdentifier/pmid/23716556.  , 2013
Link: http://hdl.handle.net/11..
 
1-15